These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32780659)

  • 21. Development of a potent Zika virus vaccine using self-amplifying messenger RNA.
    Luisi K; Morabito KM; Burgomaster KE; Sharma M; Kong WP; Foreman BM; Patel S; Fisher B; Aleshnick MA; Laliberte J; Wallace M; Ruckwardt TJ; Gordon DN; Linton C; Ruggiero N; Cohen JL; Johnson R; Aggarwal K; Ko SY; Yang ES; Pelc RS; Dowd KA; O'Hagan D; Ulmer J; Mossman S; Sambor A; Lepine E; Mascola JR; Pierson TC; Graham BS; Yu D
    Sci Adv; 2020 Aug; 6(32):eaba5068. PubMed ID: 32821824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zika virus vaccines.
    Abbink P; Stephenson KE; Barouch DH
    Nat Rev Microbiol; 2018 Oct; 16(10):594-600. PubMed ID: 29921914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review of Zika virus: hurdles toward vaccine development and the way forward.
    Haque A; Akçeşme FB; Pant AB
    Antivir Ther; 2018; 23(4):285-293. PubMed ID: 29300166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current Efforts in the Development of Vaccines for the Prevention of Zika and Chikungunya Virus Infections.
    Schrauf S; Tschismarov R; Tauber E; Ramsauer K
    Front Immunol; 2020; 11():592. PubMed ID: 32373111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rational Design of Zika Virus Subunit Vaccine with Enhanced Efficacy.
    Tai W; Chen J; Zhao G; Geng Q; He L; Chen Y; Zhou Y; Li F; Du L
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31189716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Zika virus infection: A review].
    Guillier A; Amazan E; Aoun A; Baubion E; Derancourt C
    Ann Dermatol Venereol; 2017; 144(8-9):518-524. PubMed ID: 28673675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An update on preclinical pregnancy models of Zika virus infection for drug and vaccine discovery.
    Benazzato C; Russo FB; Beltrão-Braga PCB
    Expert Opin Drug Discov; 2022 Jan; 17(1):19-25. PubMed ID: 34461793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zika Virus-Like Particle (VLP) vaccine displaying Envelope (E) protein CD loop antigen elicits protective and specific immune response in a murine model.
    Cimica V; Williams S; Adams-Fish D; McMahon C; Narayanan A; Rashid S; Stedman TT
    Biochem Biophys Res Commun; 2020 Aug; 529(3):805-811. PubMed ID: 32736711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of a T Cell-Biased Adenovirus Vector as a Zika Virus Vaccine.
    Bullard BL; Corder BN; Gorman MJ; Diamond MS; Weaver EA
    Sci Rep; 2018 Dec; 8(1):18017. PubMed ID: 30573745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strategies for Zika drug discovery.
    Zou J; Shi PY
    Curr Opin Virol; 2019 Apr; 35():19-26. PubMed ID: 30852345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hide and Seek: The Interplay Between Zika Virus and the Host Immune Response.
    Lee LJ; Komarasamy TV; Adnan NAA; James W; Rmt Balasubramaniam V
    Front Immunol; 2021; 12():750365. PubMed ID: 34745123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Live vaccine infection burden elicits adaptive humoral and cellular immunity required to prevent Zika virus infection.
    Yau C; Gan ES; Kwek SS; Tan HC; Ong EZ; Hamis NZ; Rivino L; Chan KR; Watanabe S; Vasudevan SG; Ooi EE
    EBioMedicine; 2020 Nov; 61():103028. PubMed ID: 33045466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Emergence of Zika Virus: A Narrative Review.
    Anderson KB; Thomas SJ; Endy TP
    Ann Intern Med; 2016 Aug; 165(3):175-83. PubMed ID: 27135717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zika virus: The transboundary pathogen from mosquito and updates.
    Kong W; Li H; Zhu J
    Microb Pathog; 2018 Jan; 114():476-482. PubMed ID: 29241768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maternal immunization with a DNA vaccine candidate elicits specific passive protection against post-natal Zika virus infection in immunocompetent BALB/c mice.
    Wang R; Liao X; Fan D; Wang L; Song J; Feng K; Li M; Wang P; Chen H; An J
    Vaccine; 2018 Jun; 36(24):3522-3532. PubMed ID: 29753607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone.
    Li XF; Dong HL; Wang HJ; Huang XY; Qiu YF; Ji X; Ye Q; Li C; Liu Y; Deng YQ; Jiang T; Cheng G; Zhang FC; Davidson AD; Song YJ; Shi PY; Qin CF
    Nat Commun; 2018 Feb; 9(1):673. PubMed ID: 29445153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NS1-based DNA vaccination confers mouse protective immunity against ZIKV challenge.
    Zhan Y; Pang Z; Du Y; Wang W; Yang Y; Wang W; Gao GF; Huang B; Deng Y; Tan W
    Infect Genet Evol; 2020 Nov; 85():104521. PubMed ID: 32882433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Humoral Immune Responses Against Zika Virus Infection and the Importance of Preexisting Flavivirus Immunity.
    Priyamvada L; Suthar MS; Ahmed R; Wrammert J
    J Infect Dis; 2017 Dec; 216(suppl_10):S906-S911. PubMed ID: 29267924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zika Virus Vaccine Development.
    Morabito KM; Graham BS
    J Infect Dis; 2017 Dec; 216(suppl_10):S957-S963. PubMed ID: 29267918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of vaccines against Zika virus.
    Poland GA; Kennedy RB; Ovsyannikova IG; Palacios R; Ho PL; Kalil J
    Lancet Infect Dis; 2018 Jul; 18(7):e211-e219. PubMed ID: 29396004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.